Search
for
Sort by
Research 121–150 of 1000+
- Vitiligo and Alopecia Areata as Early Signs Preceding Type 1 Diabetes Mellitus
- Hepatitis C‐related mixed type vitiligo in a patient with Ivemark syndrome
- Melanocytes and Vitiligo (and Hair Graying)
- Welche Pflanze für welche Hauterkrankung? Teil 2: Dermatophyten, chronisch‐venöse Insuffizienz, Photoprotektion, aktinische Keratosen, Vitiligo, Haarausfall, kosmetische Indikationen
- LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
- Familial coexistence of vitiligo and alopecia areata: successful treatment with intralesional corticosteroids
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Vitiligo—Current Treatment Options and Future Perspectives
- Acute Onset of Vitiligo in a Patient with Graves’ Disease and Recurrent Alopecia Areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Revealing biological mechanisms of skin pigment recovery during treatment in vitiligo patients: A proteomic analysis
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Hair follicle-derived epithelial sheet has potential in vitiligo treatment
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Synergistic delivery of ginseng exosomes and biomimetic melanosomes via temporally controlled hydrogel microneedles restrain the pathologic triad of vitiligo
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Combination Therapy with 308-nm Excimer Laser, Compound Glycyrrhizin, and Tacrolimus for Pediatric Facial and Cervical Vitiligo
- Study of Nonculture Epidermal Suspension in the Treatment of Stable Vitiligo
- Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo
- Aesthetic Procedures in Patients with Vitiligo: Evidence-Based Clinical Guidelines for Minimizing Koebner Phenomenon Risk
- Systemic corticosteroids in vitiligo: Evidence-based insights and practical considerations
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- 448 Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo
- Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areata
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib